SV3DPrinter solutions and prediction for 3d Printing market
According to Dr. Souhail Al-Abed, lead EPA scientist of a new study on the subject,” Users may not be aware of chemical emissions during the printing process. His team’s research shows that common 3D printer ink, or filament, can emit gases during the printing phase that may pose a health risk to users and bystanders. The most concerning of these emissions are known as volatile organic compounds, or VOCs for short.”
For instance, HP says that 3D printing will enable the manufacturing industry to produce less waste, less inventory and less CO2 emissions. It allows engineers and designers to rethink design throughout the product lifecycle in order to use less material and reduce waste by combining parts and using complex geometries to produce lightweight parts.
As reported by Experimental Eye Research, ” how stem cells (human corneal stromal cells) from a healthy donor cornea were mixed together with alginate and collagen to create a solution that could be printed, a ‘bio-ink’.
Using a simple low-cost 3D bio-printer, the bio-ink was successfully extruded in concentric circles to form the shape of a human cornea. It took less than 10 minutes to print.”
On the authority of Che Connon, Professor of Tissue Engineering at Newcastle University, who led the work, “Many teams across the world have been chasing the ideal bio-ink to make this process feasible.
Our unique gel – a combination of alginate and collagen – keeps the stem cells alive whilst producing a material which is stiff enough to hold its shape but soft enough to be squeezed out the nozzle of a 3D printer.
This builds upon our previous work in which we kept cells alive for weeks at room temperature within a similar hydrogel. Now we have a ready to use bio-ink containing stem cells allowing users to start printing tissues without having to worry about growing the cells separately.”
According to Sam Davies, “We are developing a new wave of solutions that have the potential to transform how we heal injury and disease.”
According to Tamer Mohamed, CEO, Aspect Biosystems, “We are thrilled to close this important institutional financing round with a group of world-class investors who believe in our bold vision. This funding speaks to the power of our technology and strategy in addressing multiple applications in therapeutic discovery and regenerative medicine, and will allow us to accelerate internal innovation and expand our global partnerships. With our technology platform, interdisciplinary team of scientists and engineers, and leading collaborators, we are developing a new wave of solutions that have the potential to transform how we heal injury and disease.”
According to Jordan Jacobs, managing partner, Radical Ventures, “We are very excited to partner with the excellent Aspect team to support the growth of their world-leading 3D bioprinting platform and the development of breakthrough technologies aimed at radically transforming human health.
In the opinion of Lead author and Ph.D. candidate from RMIT University’s School of Engineering, Carmelo Todaro, “the promising results could inspire new forms of additive manufacturing.
If you look at the microscopic structure of 3-D printed alloys, they’re often made up of large and elongated crystals.
This can make them less acceptable for engineering applications due to their lower mechanical performance and increased tendency to crack during printing.
But the microscopic structure of the alloys we applied ultrasound to during printing looked markedly different: the alloy crystals were very fine and fully equiaxed, meaning they had formed equally in all directions throughout the entire printed metal part.”
Dinsmore Inc. was founded by Jay Dinsmore, a winner of the 2019 Distinguished Innovator Operators Award (DINO) and an outspoken advocate and educator for Additive Manufacturing and 3D Printing technologies.
As mentioned above about Dinsmore team,” the team design the CAD model and shape of each 3D printed midsole to fit the specific TEVA and UGG shoes that they were bonded to custom, 3D printed orthotics for Imre Patterson, a young boy who was born with a femoral discrepancy (causing one leg to be shorter than the other). Using breakthroughs in both 3D printing technology and materials designed an alternative to his traditional manufactured foam boot using Carbon’s Digital Light Synthesis™ (DLS) technology to 3D print a lightweight, latticed midsole. This is the same technology used to manufacture the midsoles of Adidas 4D Futurecraft shoes.”